5–8 percent of the anti-AChR negative MG patients, have MG induced by antibodies to muscle-specific tyrosine kinase (MuSK) [10], [11], and in 3–9 percent to low-density lipoprotein receptor-related protein 4 (LRP4) [12]–[14]. This evidence concerns the gene LRP4 and myasthenia gravis.